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Rearrangement of Ig genes proceeds during B cell differentiation in an orderly
fashion . First the heavy (H) chain gene is rearranged in pre-B cells . These cells can
express cytoplasmic A chain but no light (L) chain (1). The K light chain genes rear
range next and if they fail to produce a functional gene on either chromosome the
X light chain genes are rearranged (2) . It is generally believed that the expression
of an Ig molecule on the cell surface triggers a feed-back mechanism that shuts off
the rearrangement process (3, 4) . Continuous rearrangement of light chain genes
has been reported in some pre-B cell lines transformed with Abelson murine leukemia
virus (A-MuLV)' (5) . Nevertheless, mature B cells that express surface Ig (sIg+)
generally maintain their functionally rearranged Ig genes and remain committed
to express antibodies composed of those same H and L chains . Here we show that
a sIg+ B cell can alter its surface receptor by continuing to rearrange its K light chain
locus .
We have previously isolated Ig variants (6) of 38C13, a carcinogen-induced mu-
rine B cell lymphoma (7) . These variants arose in tumor-bearing animals that were
treated with antiidiotypic mAbs . Although a high percentage of the animals were
cured, some developed tumors despite the therapy. Analysis of the variant cells re-
vealed that they expressed sIg but failed to react with the antiidiotypic antibody.
mAbs were produced that could discriminate between the Ig produced by the pa-
rental tumorand by each ofthe variants . Further analysis showed that the Ig protein
expressed by the variants contained identical heavy chains but differed in their light
chains . Southern blot analysis showed identical rearrangements at theH chain locus
and established that the variants were clonally related . However, the variants differed
from each other in their L chain gene rearrangement patterns .
The Ig V region genes expressed by these variants were cloned and sequenced .
As expected, the VH genes were identical in all variants and in the parental 38C13
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ONGOING REARRANGEMENT OF VK GENES IN A B CELL LINE
tumor (8). However, the sequences of the V, genes were all different. Whereas the
parental V, was derived from the VK9 family and joined to JK2, the V,, genes of the
variants were derived from the V-Oxl gene family and joined to JK4. Two of the
variants used the identical V gene but differed by the inclusion of variable numbers
of additional nucleotides at the V/J joints (8).
These variants were selected, in vivo, from a parental population that contained
cells with different rearrangements of the VK locus (6). Such variants could have
arisen at the pre-13 cell stage from a common precursor that had rearranged its heavy
chain gene but had not yet chosen a light chain gene. Alternatively the variants could
have been generated at the B cell stage by ongoing light chain gene rearrangements.
To distinguish between these possibilities, we have now subcloned the tumor and
subjected it to immunoselection in vitro with a toxin-conjugated antiidiotypic anti-
body. We find that the cloned tumor cell gives rise to variants and these variants
can, in turn, give rise to new variants, which all differ in their VK genes . The new
V region genes are mostly drawn from the V-Oxl gene family. Interestingly, some
members of this family are used repetitively. In this mature B cell tumor, successive
VK rearrangements occur between members of the V-Oxl family and progressive
downstream J segments. These findings suggest yet another mechanism by which
clonal diversity can be generated in Ig-producing cells .
Materials and Methods
Cell Lines.
￿
The 38C13 murine B cell tumor and the tumor variants VI-V4 have been de-
scribed previously (6). The cell lines were maintained in tissue culture as detailed previously
(6). New idiotypic variants were derived either by the use of antiidiotype immunotoxin or
by subcloning. The immunotoxin was prepared by coupling antiidiotypic mAb S5A8 to the
A chain of ricin and was kindly provided by Drs. G. Apell and L. Houston (Cetus Corp.,
Emeryville, CA). This immunotoxin was used for the selection of variants using methods
that were previously detailed (6). Alternatively, cells with spontaneous alteration of idiotype
expression, as determined by FRCS analysis, were sorted and subcloned. The subcloned cell
lines were analyzed again by FAGS and new variants were identified by their reactivity with
a panel of antiidiotype antibodies (Table I).
Antiidiotypic Antibodies.
￿
The generation and characterization ofthe original syngeneic and
rat antiidiotype mAb to the parental 38013 idiotype protein has been described (9). The
isolation of the idiotype proteins produced by the tumor variants VI and V3 as well as the
preparation of syngeneic antiidiotype mAb against these variant idiotypes has also been de-
scribed previously (6).
Determination of the Rate ofIdiotypic Variation.
￿
Tumor cells were cloned at limiting dilution
in 96-well U-bottomed plates (Costar, Cambridge, MA) in RPMI medium containing 10%
FCS. Clones were grown for 5 d then harvested and cytocentrifuged onto microscope slides.
Cytospun cells were fixed in cold acetone for 10 min immediately before staining with an-
tiidiotype antibody (SIC5) coupled to horseradish peroxidase (HRP) or with HRP-conjugated
polyclonal goat anti-mouse K (Tago Inc., Burlingame, CA) for 45 min at room temperature.
After washing in PBS the slides were developed with AEC (3-amino-9-ethylcarbazole) sub-
strate (Sigma Chemical Co., St. Louis, MO) in N,N-dimethyl formamide diluted to 6.7%
in 0.1 M acetate buffer, pH 5 .2, with 0.03% hydrogen peroxide for 30 min at 37°C. The
slides were then washed in PBS and counterstained in 0.1 % fast green FCF (Sigma Chemical
Co.) for 5 minutes.
Clones stained for idiotype or Ig expression were scored by visual inspection. Clones in
which all cells (or the majority ofcells) were negative arose from variants present in the original
culture and were thus not included in the rate calculations. The rate of idiotypic variation
(RIV) was estimated using the Po method of Luria and Delbruck (10). The fraction of clones
containing no variant cells, Po, was determined. The mean number of mutational events perO
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ONGOING REARRANGEMENT OF VK GENES IN A B CELL LINE
well, m, was estimated from the Poisson formula Po = e--. The variation rate per cell per
generation was then calculated using the formula:
RIV = m(In2)
N -No
where N was the average number of cells per clone, and No was the number of cells initi-
ating the clone, in this case 1. Even if some clones arose from two or three cells, this would
not significantly effect the calculation of RIV, since N was three to four orders of magni-
tude higher. In addition, since only the presence or absence of variants in a clone is scored,
it is irrelevant whether they grow faster or slower than the parental cells.
The variance (var)of RIV and the coefficient of variance (CV), a measure of the precision
in the estimate of RIV were calculated as described by Li et al. (11):
var(RIV) = I-PO
CN2Po
where C is the total number of clones screened, and
CV = var(RIV)
RIV
Sequencing of VK Genes.
￿
Total RNA was extracted from the tumor variants using the
guanidinium thiocyanate method (12), poly(A)' mRNA was isolated by oligo(dT) chroma-
tography (13). V region cDNA was synthesized using a Cx primer and reverse transcrip-
tase, made double stranded by the method ofGubler and Hoffman (14) and inserted directly
into the Sma I site of ml3mp19 as detailed (15). The m13 libraries were screened with a VK
gene (8). Positive clones were identified and single-stranded templates were sequenced (16).
Results
Primary, Secondary, and Tertiary Idiotypic Variants Can Be Derivedfrom a Cloned sIg+ B
Cell Tumor. To test if light chain heterogeneity could be generated as an ongoing
process in this fully differentiated B cell, the 38C13 tumor was repetitively cloned
and immunoselected in vitro (Fig. 1). These derivative clones were then analyzed
with a panel of mAbs that react with different idiotypic determinants (Table I).
At the start of the experiment a subclone of 38C13 cells was expanded and then
treated with an immunotoxin made from the antiidiotype antibody S5A8 (6). The
cells that eventually grew were mostly sIg- however, some of the cells expressed sur-
face Ig (slg+). When analyzed with a second anti-Id antibody, SIC5, these sIg` cells
contained two separate populations, as shown in Fig. 2. Prototypes of each of these
two cell populations were then isolated by subcloning, giving rise to tumor variants
V4.0 and V6 (Fig. 1). The reactivity pattern of tumor variant V4.0 with a panel
of antiidiotypic mAbs (Table I) was identical to that of the previously, and indepen-
dently, isolated variant V4 (6) . Surprisingly, the tumor variant V6 retained reac-
tivity with anti-Id antibody S5A8, despite the fact that it was selected by exposure
to the S5A8 immunotoxin . This tumorvariant, V6, was then reexposed to a 10-fold
higher concentration of the S5A8 immunotoxin and gave rise to the variant V6.1.
This second generation variant exhibited a reactivity pattern different from V6 but
identical to that of the independently derived tumor variant Vl (Table I), hence
the nomenclature. These common reactivity patterns between independently de-immunotoxin
immunotoxin
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FIGURE 1 .
￿
Genealogyof38C13 cell variants. Idiotype variants of the 38C13 tumorwere selected
as indicated. Antiidiotypic antibody SIC5 was used formAb therapy in vivo. Antiidiotypicanti-
body S5A8 wasconjugated to ricinAchainandthis immunotoxin wasused forselectionin vitro.
In addition, cell linesthat demonstrated alterations in their FACS profiles were sorted andsub-
cloned as indicated.
rived variants are explained by the nucleic acid sequence analysis of their V,I genes
(see below).
Second and third generation variants were derived from the tumor variant V1,
which had been previously isolated by immunoselection in vivo with the antiidio-
typic mAb SIC5 . To begin this experiment the variant Vl was subcloned and grown
in culture for N3 mo. The resulting cell population was then reanalyzed for idio-
type expression and demonstrated to be heterogeneous. Sorting and subcloning of
these cells resulted in the isolation of the tumor variants V7 and V8 (Fig. 1 and
Table 1). Some of the clones demonstrated a unique "converter" phenotype. That
FIGURE 2.
￿
FACS analysis of im-
munotoxin resistant 38013. Sub-
cloned 38013cells were treatedwith
antiidiotype immunotoxin (S5A8-
ricinA chain). Resistantcellswere
stained with a different antiidio-
typicantibody SIC5 and analyzed
with the FACS. Theresistant cells
were predominantly sIg. The
sIg' cells showed two different
levels ofstaining intensity. Variants
V4.0 andV6 were isolated by sub-
cloning cells from these two cell
populations, as indicated.6
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is, from a population that was >95% slg- when stained initially after recloning, the
cell population became progressively more slg' with time. This change was detected
as early as 10 d in culture. As the subclones converted to become slg', reactivity
with some antiidiotype mAbs was detected. This allowed the sorting and cloning
of the tumor variant cell lines V9 and V15 (Fig. 1 and Table I). Third generation
variants (V10, V11, V12, and V16) were obtained from tumor variants V7 and V8
(Fig. 1) by selection in vitro with the immunotoxin.
Rate of Generation of Idiotypic Variants.
￿
The rate at which idiotypic variants were
being generated in vitro was determined by fluctuation analysis. Individal subclones
of 38C13 were grown for 5 d to an average of 8859 cells. 58 of these colonies were
stained for idiotype expression and 53 were found to contain some Id- cells. Using
the Po method of Luria and Delbruck (10), the rate of idiotypic variation was esti-
mated to be 1 .92 x 10-4 per cell per generation (Table II).
Since cells that do not stain with the antiidiotype antibody could be either Ig'/Id-
or simply Ig- variants, we also examined the rate of generation of Ig loss variants
in the 38C13 cell line. Of 41 colonies analyzed with an antibody directed against
the murine K light chain, 22 contained some negative cells. As shown in Table II,
the resulting rate of K chain loss was estimated to be 6.01 x 10-5 per cell per
generation.
Idiotypic Variants Are Generated by Continuing Rearrangement of K Light Chain Genes.
Messenger RNA was isolated from the tumorvariants and cDNAs for their expressed
V,, genes were cloned and sequenced. Fig. 3 contains the sequences of transcripts
from the slg' variants V6, V6.1, V8, V7 and from the sIg- variant V2 . The nucleo-
tide sequence of the V2 transcript was out of reading frame beginning at the exon
junction within the leader region at codon -4 (not shown in the figure). Thus, it
was probably a splicing mutant. TII is a second nonfunctional transcript that was
isolated from V6, V6 .1, and V7. The TII transcript has an additional base at the
V/J joint (the boxed A in Fig. 3). This causes the J and C region to be out of the
appropriate reading frame. All these sequences are displayed along with certain pre-
viously published members of the V,-Oxl germ line gene family (NQ10 [17], R2,
H3 and H6 [18]).
A. Successive Variants Express New V,r GenesDrawn Predominantlyfrom the V,,-Ox1 Family.
TABLE II
Variation Rate Measurements in the 38C13 B Lymphoma Cell Line
Id- K-
Total clones (C) 58 41
Initial cell no. (N,) 1 1
Average final cell no. (N) 8,859 8,859
Clones containing variants 53 22
Clones containing no variants 5 19
P 0.0862 0.4634
rn 2.45 0 .77
RIV 1 .92 x 10 -4 6.01 x 10-5
var(RIV) 2.33 x 10-" 3.60 x 10-"'
CV 0.25 0 .32CQR1
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Nucleotide sequences ofVK DNA. The nucleotide sequencesarenumbered according
to Kabat et al. (35) and grouped in codons. Thecomplementarity determining regions (CDR
1-3) are indicated, as well as theJ regionsused. NQ10 (NQ10.4.61) is apreviously reported mRNA
sequence (17); R2, H3, and H6 arepreviously reported BALB/c germline sequences(18) ofthe
VK-Ox1 gene family. TheboxedA at the V/Jjoint in the TII (transcript II)changes the reading
frame of the J and constant regions.
Each of the variants expressed VK genes that were different from that ofthe 38C13
cell from which they were all derived (Fig. 4). The striking finding was that all but
one ofthese newly expressed VK genes was a member ofthe VK-Oxl family (Fig.
3). The V6 transcript and that ofour previously published V3 and V4 variants (8)
used a V,-Oxl gene that was almost identical to the one used by hybridoma
NQ10.4.61 (17). The V6.1 transcript andthat ofourpreviously publishedV1 variant
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FIGURE 4.
￿
Summary of transcripts.
The transcripts expressed by 38C13
and all of the tumor variants that have
been sequenced to date are given, in-
cluding data obtained previously for
Vl, V3, and V4 (8). Repeated usage
of the various VK-Oxl gene family
members as well as the J region used
by each of the transcripts is indicated.
The asterisk indicates that the V2 tran-
script is out ofthe appropriate reading
frame (starting shortly after the leader
exon); the A at the V/J joint of tran-
script 11 changes the reading frame of
this transcript as well. The extra
nucleotides (n) at the V/J junction are
given for the V3 and V4.
(8) used a VK gene that was almost identical to the R2 (18) germline gene. The VK
gene used by the V8 transcript was identical to the H3 gene (18). The VK gene of
TII, the second nonfunctional transcript isolated from V6, V6.1, and V7, was iden-
tical to the H6 gene (18). The V2 transcript, also nonfunctional, used still another
member of the V,-Oxl family, but no germline version of this gene has been
reported. OnlyV7 expressed a VK gene that was not a member ofthe V,-Oxl family.
It had a long CDR1, with four extra amino acids 27 a-d (35) (Fig. 3). This gene
was most homologous to the VK gene isolated from the myeloma W3129 (19).
Althoughthe identicalVgene was expressed byV3, V4, andV6 andthe identical
V gene was expressed by V6.1 and V1, these were all independent rearrangement
events. This was evident because ofthe variations in the V/Jjoints or in the choice
ofJ segments, as indicated in Fig. 4. On the other hand the rearrangement that
gave rise to the nonfunctional transcript TII was common to variants V6, V6.1, and
V7 and tied thesethreevariants to acommon precursorcell. Since V6.1 wasderived
directly from V6 and since they shared a common nonfunctional transcript TII,
the functional VK gene NQ 10.4.61 joined toJ4 in V6 must have been replaced by
a subsequent rearrangement ofthe R2 gene to the downstream J5 segment to give
rise to V6.1.
B. Downstream J Regions Are Used in the Second and Third Generation Variants.
￿
The
38013 VK gene was joined toJ2 while all of the variants derived from this tumor
used either theJ4 or theJ5 gene segments. Analysis of second generation variants
that gaverise, directly, tothirdgeneration variants showed that these second genera-
tion variants were using theJ4 for their active transcript (Vl and V6). By contrast,
the third generation variants (V6.1, V7, andV8) all used theJ5 fortheir active tran-
script (Figs. 3 and 4).
Discussion
The murine 38013 B cell lymphoma has been used as a model system to study
antiidiotype therapy (9). This B cell tumor expresses sIg protein and responds to
therapy directed against the idiotypic determinants. In this respect it is similar to
human B cell lymphomas. We have previously found that the Ig genes expressed
TRANSCRIPT I TRANSCRIPT II
38C13
(Vk9) / J2
V3
N010 .4 .61 (0x1) n7/_!4-
V4 N010 .4 .61 (0x1) n2/ A_
V6
N010 .4 .61 (0x1) / H6 (0x1) A/_14
V6 .1 R2 (0x1) / H6 (0x1) A/-.44
V1
R2 (0x1) / -IL-_
V8
H3 (0x1) /
V2
(Ox-1) /
V7 / H6 (0x1) A/_14LEVY ET AL.
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by certain human B cell tumors undergo somatic point mutation (20). In a search
for an in vitro system that exhibits such Ig gene point mutation, we analyzed the
tumors that had escaped anti-Id therapy in this mouse model. However, analysis
ofthe 38C13 tumorvariants revealed that they ceased to react with the antiidiotypic
antibodies not because they had undergone somatic mutation but because they ex-
pressed new VK genes (8).
The question then arose whether these tumor variants were present in the pa-
rental population and were merely selected by the anti-Id antibody therapy. Anal-
ysis ofthe parental population revealed heterogeneity at the VK locus and it was pos-
sible that the variants arose during some early stage in the evolution ofthis tumor.
We therefore subcloned the tumor and followed the VK locus in these clones. Here
we demonstrated that subclones ofthis tumorcould give rise to new tumor variants
and that these variants could give rise to subsequent variants. For example, the V6
tumor was derived from the subcloned 38C13 and the V6.1 tumor was derived, in
turn, from the V6 tumor (Fig. 1).
Continuous rearrangement ofVK genes has been previously observed in A-MuLU
transformed pre-B cell lines (5). This phenomenon was documented by studying
the rearrangements ofthe VK genes by Southern blot analysis. However, the actual
VK and JK genes that were involved in these new rearrangements were not identified.
Othergroups havedescribed multiple rearrangement events that had occurred during
the differentiation ofB cells before the formation ofan active VK allele (21-23). How-
ever, in these examples VK gene rearrangement ceased once a functional gene was
produced.
The continuously rearranging A-MuLVtransformed cell lines are pre-B cells in
which the enzymes involved in the V/J recombination arestill active (24). A plasmid
substrate has recently been used to test cell lines for the presenceofan active recom-
bination system (25). As expected, pre-B cells regularly exhibited such activity, but
in addition, one mature B cellline, BALB-1427, was found toexhibit an active recom-
binase.
As we have shown here, the 38C13 B cell tumor and its various variants undergo
continuous rearrangement oftheir Ig VK genes. These rearrangement events are re-
stricted almost exclusively to a single VK gene family, whose members are used repeti-
tively by independent tumor variants (Fig. 4). Biased usage ofVK genes ofthe same
family has been previously described (23, 26). It is possible that in the 38C13 tumor
an initial functional rearrangement event brought a particular set of upstream V
region genes closer to the J region. Such proximity to the J genes could enhance
the usage of certain VK genes, similar to that described for proximal V genes in
early B cell development (2). This might explain the repeated usage ofthe VK gene
family members in the new rearrangements that occurred in the 38C13 tumor vari-
ants. If this explanation for the repetitive use of the V,,-Oxl family is valid, then
it would imply that the members of this family used here are clustered.
Somaticpointmutation does not occur in this B cell tumor. We know this because
the genes expressed by C3H tumor cells were either almost identical or identical to
germline genes previously sequenced from BALB/c mice (18). Moreover, repetitive
isolates of the expressed genes were identical to each other. Similarly, the V gene
expressed by the parental tumor and its variants is identical to a germline gene,
V11 of NZB mice (27).
The use of the same VK gene in three independent variants points out still an-10
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other interesting feature ofthese light chain gene rearrangements. The V/J joint
invariantV4 contains two extranucleotides and also ismissing onenucleotide from
the 5' end of theJ segment. Likewise, the light chain gene of the V3 variants has
seven extra nucleotides at the V/J junction (nucleotides missing from the 5' end of
theJ segment bring the transcript back into the proper reading frame) (8). Long
light chain transcripts containing members of the V,,-Oxl family have previously
been observed and are assumed to be the products of independent genes (28). By
analogy it is possible that these three variants express independent genes. But it is
more likely that the extra nucleotides are N nucleotides similar to those seen at
V./D./J. junctions (2). N nucleotides have only rarely been reported in light chain
genes both in mouse (29) and in human (30). It has been suggested that Nnucleo-
tides are the products of the enzyme terminal deoxynucleotide transferase (TdT)
(31). We have previously shown that the 38C13 cells express TdT mRNA (8).
Despite the repeated usage ofthe sameVregion gene, theinclusionofextra nucleo-
tides at the V/J junction created Ig proteins that differed from each other by one
to three amino acids. Such changes caused marked differences in reactivity ofsome
of the Ig products with a panel ofantiidiotypic antibodies (Table I). However, no
changes in the reactivity ofthe VI and the V6.1 were detected, even though these
two variants (which used the identical V,, gene but differentJ regions) also differed
from each other by three amino acids. Thus, the epitopes recognized by some of
the antiidiotypic antibodies were dependent upon the aminoacids at the V/Jjunction.
The parental 38C13 used theJ2 gene segment. The next generation variants used
J4, the next functional downstream J region in the mouse. As new variants arose
they always usedJ region genes that are still further downstream. For example, the
V6.1 tumor usedJ5 and the tumorfrom which itwasderived, V6, used theJ4 gene.
Both ofthese variants were shown to express an identical aberrant transcript (TII
in Figs. 3 and 4). Therefore, in this case, the allele that underwent the tertiary rear-
rangement can be clearly identified.
Some variants ofthe 38C13 tumor were derived by selection with an antiidiotype
immunotoxin. However, others arose spontaneously during passage in vitro. As an
example, the VI variant when left in culture for 3 mo developed new variants. The
rate at which variants of 38013 were being generated in vitro was estimated to be
6.01 x 10-5 per cell per generation for Ig- variants and 1.92 x 10-4 per cell per
generation for Id- variants (which includes Ig- as well as Ig+/Id- cells). These rates
are comparable to those reported byWabl and co-workers forVregion somatic mu-
tation (32), suggesting thatcontinued K chain rearrangement may representanother
source ofidiotypic variation that could result in escape from antiidiotype therapy.
The rate ofvariant generation was measured for the parental 38013. Some cell
lines derived from the V1 variant and initially exhibiting a sIg- phenotype converted
to sIg` after as little as 10 d of culture. Other semiquantitative experiments (data
not shown) indicate that a surface Ig- state (converter sIg- phenotype, Fig. 1) can
be an intermediate step in the generation of variants. This observation is concor-
dant with the proposed mechanism of feedback by the Ig protein on new V, rear-
rangements. Indeed it may be that a sIg- state is an obligatory step in the induc-
tion of the new rearrangement process, but this has not been proven.
In human B cell tumors, escape from antiidiotype therapy was found to be ex-
plainedby a known mechanism forgeneration ofdiversity in Iggenes: somatic pointLEVY ET AL .
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hypermutation. In the mouse tumor described here, escape from antiidiotype therapy
was due to a different mechanism: continuing light chain rearrangement. We have
recently observed a similar process in the X locus of a human B cell line, derived
from a large cell lymphoma (33). In addition, secondary rearrangements ofthe TCR
V« genes to downstream Ja segments have recently been shown to replace pre-
existing and functional V,/J, genes in a T cell line (34). It is possible that this is
a general mechanism for the generation of Ig and TCR diversity that has not been
previously appreciated. This process can be detected only when the progeny ofsingle
cells can be recovered and analyzed, such as in cell lines. The study of cells par-
ticipating in a normal immune reponse does not easily lend itselfto such an analysis.
Summary
A murine B cell lymphoma (38C13) was subjected to immunoselection with mAbs
directed against the idiotypic determinants of its cell surface Ig. Variants emerged
with altered Ig receptors containing identical heavy chains but different light chains.
The functional light chain genes in these variants were composed of VK segments
drawn from the VK Ox-1 family, which had replaced the VK gene expressed by the
parental tumor by rearranging to downstream JK segments. Rearrangement at the
Klocus continued to occur spontaneously, giving rise to secondary and tertiary vari-
ants at a rate of 1.9 x 10 -4 per cell per generation. Variants were isolated that had
ceased production of surface Ig but went on to rearrange again and to become sur-
face Ig+ . The Ig- state may be an intermediate step providing a stimulus for con-
tinued rearrangement. This process provides an additional mechanism for gener-
ating diversity within B cell clones and expands the use of the available repertoire
of Ig genes.
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